Anat Guz‐Mark

Proactive Monitoring of Adalimumab Trough Concentration Associated With Increased Clinical Remission in Children With Crohn’s Disease Compared With Reactive Monitoring

Amit Assa, Manar Matar, Dan Turner et al. · Gastroenterology · 2019 · 254 citations

Medicine, Immunology, Pediatrics +16

Premature Thelarche: Age at Presentation Affects Clinical Course but Not Clinical Characteristics or Risk to Progress to Precocious Puberty

Liat de Vries, Anat Guz‐Mark, Liora Lazar et al. · The Journal of Pediatrics · 2009 · 76 citations

Medicine, Child Health, Pediatrics +16

Combination Therapy of Adalimumab With an Immunomodulator Is Not More Effective Than Adalimumab Monotherapy in Children With Crohn’s Disease: A Post Hoc Analysis of the PAILOT Randomized Controlled Trial

Manar Matar, Raanan Shamir, Dan Turner et al. · Inflammatory Bowel Diseases · 2019 · 37 citations · Full text

Life Sciences, Immunology, Pharmacotherapy +17

Chronic Intestinal Failure in Children: An International Multicenter Cross-Sectional Survey

Antonella Lezo, Antonella Diamanti, Evelyne Marinier et al. · Nutrients · 2022 · 32 citations · Full text

Agriculture, Nutrition, Pediatrics +17

Duodenal intraepithelial lymphocytosis is common in children without coeliac disease, and is not meaningfully influenced by <i>Helicobacter pylori</i> infection

Anat Guz‐Mark, Noam Zevit, Sara Morgenstern et al. · Alimentary Pharmacology & Therapeutics · 2014 · 24 citations · Full text

Medicine, Pathology, Pediatrics +15